Litigation
Eli Lilly and Company v. Impax Laboratories, Inc.
resolvedAuto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Terminated
- 2011-04-27
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Lilly sued Impax Laboratories in the S.D. Ind. Cymbalta/duloxetine HCl ANDA litigation over US 5,023,269. The suit was announced on November 18, 2008, and the case was resolved within the April 27, 2011 Cymbalta order/dismissals (not independently confirmed).
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).